CTC Spray 78.6 mg/g, Cutaneous Spray, Suspension for Pigs, Sheep and Cattle

Страна: Великобритания

Език: английски

Източник: VMD (Veterinary Medicines Directorate)

Активна съставка:

Chlortetracycline Hydrochloride

Предлага се от:

Eurovet Animal Health B.V.

АТС код:

QD06AA02

INN (Международно Name):

Chlortetracycline Hydrochloride

Лекарствена форма:

Cutaneous spray, suspension

Вид предписание :

POM-V - Prescription Only Medicine – Veterinarian

Терапевтична група:

Cattle, Pigs, Sheep

Терапевтична област:

Antimicrobial

Статус Оторизация:

Authorized

Дата Оторизация:

2015-12-14

Данни за продукта

Revised: February 2024
AN: 03986/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
CTC Spray, 78.6 mg/g, cutaneous spray, suspension for pigs, sheep and
cattle
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains :
ACTIVE SUBSTANCE:
Chlortetracycline HCl
78.6 mg
(equivalent to chlortetracycline
73.0 mg)
EXCIPIENTS:
Patent Blue V (E131), colouring agent
4.8 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Cutaneous spray, suspension.
Blue coloured spray.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, sheep and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Supportive treatment of infections of superficial traumatic origin or
surgical
wounds caused by micro-organisms sensitive to chlortetracycline. The
veterinary medicinal product can be used as part of a treatment for
superficial
foot infections, in particular interdigital dermatitis (foot rot) in
sheep, and digital
dermatitis in cattle.
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: February 2024
AN: 03986/2022
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Protect the eyes of the animal when spraying in the vicinity of the
head.
The animal should be discouraged from licking the treated area, or
treated
areas on other animals.
Susceptibility testing and official, national and regional
antimicrobial policies
should be taken into account when the veterinary medicinal product is
used.
Use of the veterinary medicinal product deviating from the
instructions given in
the SPC may increase the prevalence of bacteria resistant to
chlortetracycline
and may decrease the effectiveness of treatment with other
tetracyclines, due to
the potential for cross-resistance.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Direct contact with the skin should be avoided b